ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS(AHI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AHI ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS

Halted 05-13 16:00:00 EDT

1.50

+0.00

0.00%

High1.50	Low1.50	Vol0.00
Open1.50	D1 Closing1.50	Amplitude0.00%
Mkt Cap13.16M	Tradable Cap9.50M	Total Shares8.77M
T/O0.00	T/O Rate0.00%	Tradable Shares6.34M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"AHI","market":"US","secType":"STK","nameCN":"ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS","latestPrice":1.5,"timestamp":1715630400000,"preClose":1.5,"halted":3,"volume":0,"delay":0,"floatShares":6336044,"shares":8773335,"eps":-1.474571,"marketStatus":"Halted","change":0,"latestTime":"05-13 16:00:00 EDT","open":1.5,"high":1.5,"low":1.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.474571,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1715673600000},"marketStatusCode":5,"adr":0,"adrRate":28,"listingDate":1637298000000,"exchange":"NASDAQ","adjPreClose":1.5,"volumeRatio":0},"requestUrl":"/m/hq/s/AHI","defaultTab":"news","newsList":[{"id":"2434890528","title":"Advanced Human Imaging Ltd. Tackles Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2434890528","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434890528?lang=en_us&edition=fundamental","pubTime":"2024-05-11 06:28","pubTimestamp":1715380092,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. Unsponsored Adr (AHI) has released an update. Advanced Human Imaging Ltd. has been notified by Nasdaq of a shareholder ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-ltd-tackles-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-ltd-tackles-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2434849428","title":"AHI and Kalibra Unveil Next-Gen Personalized Health App","url":"https://stock-news.laohu8.com/highlight/detail?id=2434849428","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434849428?lang=en_us&edition=fundamental","pubTime":"2024-05-10 15:37","pubTimestamp":1715326669,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Health Intelligence Ltd. has partnered with Singapore-based Kalibra Pte Ltd t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ahi-and-kalibra-unveil-next-gen-personalized-health-app?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ahi-and-kalibra-unveil-next-gen-personalized-health-app?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2432518436","title":"Advanced Human Imaging Announces Q1 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2432518436","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2432518436?lang=en_us&edition=fundamental","pubTime":"2024-05-02 05:29","pubTimestamp":1714598980,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. Unsponsored Adr (AHI) has released an update. Advanced Human Imaging Ltd. has reported significant growth and strategic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-announces-q1-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-announces-q1-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2430101997","title":"1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On","url":"https://stock-news.laohu8.com/highlight/detail?id=2430101997","media":"Motley Fool","top":-1,"share":"https://ttm.financial/m/news/2430101997?lang=en_us&edition=fundamental","pubTime":"2024-04-27 21:15","pubTimestamp":1714223700,"startTime":"0","endTime":"0","summary":"Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications.","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773981%2Fgettyimages-170619155.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773981%2Fgettyimages-170619155.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/04/27/1-unstoppable-pharmaceutical-stock-investors/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428663666","title":"Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2428663666","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2428663666?lang=en_us&edition=fundamental","pubTime":"2024-04-19 21:15","pubTimestamp":1713532500,"startTime":"0","endTime":"0","summary":"This week, J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed results. Eli Lilly’s LLY tirzepatide, which is marketed as Mounjaro for diabetes and Zepbound for obesity, succeeded in late-stage studies for obstructive sleep apnea . AbbVie’s ABBV phase III study on its successful drug Rinvoq  for treating giant cell arteritis  met its primary endpoint and key secondary endpoints. Roche’s RHHBY combination study evaluating its marketed lymphoma drug, Columvi,for earlier line of use met its primary endpoint of overall survival .AbbVie’s Rinvoq Meets Goal in Giant Cell Arteritis Study: AbbVie announced positive data from the phase III SELECT-GCA study eval","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1H9NqoSNLfLtMd2fyMlfBA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1H9NqoSNLfLtMd2fyMlfBA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-jnjs-q1-131500254.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428455509","title":"ScoPo’s Powerplays: Nowhere to hide as ASX health stocks tumble in broader selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2428455509","media":"Stockheads","top":-1,"share":"https://ttm.financial/m/news/2428455509?lang=en_us&edition=fundamental","pubTime":"2024-04-19 12:04","pubTimestamp":1713499459,"startTime":"0","endTime":"0","summary":"ASX health stock fall in past five days in line with broader markets as economic and geopolitical factors weigh heavily. ResMed falls as Eli Lily reports positive Phase 3 results of weight-loss drug in obese people with obstructive sleep apnoea. ImpediMed introduces measures to grow sales, reduce operating costs and boosts leadership team. The study follows the recent announcement of the South Australian Inquiry into endometriosis, and the Australian Government’s 2022-23 Budget commitment of $58.3 million commitment to improving women’s health, in particular endometriosis and pelvic pain.UniSA researcher and PhD candidate Amelia Mardon says learning how pain works is pivotal to managing persistent pain.“But while preliminary evidence suggests that pain science education can help women with persistent pelvic pain, there has been little information about what these consumers value learning,” Mardon says.“This study addresses this gap by capturing people’s experiences of persistent pelvic","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/04/Scott-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/04/Scott-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/scopos-powerplays-nowhere-to-hide-as-asx-health-stocks-tumble-in-broader-selloff/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428134195","title":"Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2428134195","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2428134195?lang=en_us&edition=fundamental","pubTime":"2024-04-18 20:51","pubTimestamp":1713444660,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company LLY announced that its pipeline candidate, tirzepatide, met all primary and key secondary endpoints in two phase III studies evaluating it in adults with obstructive sleep apnea  and obesity.OSA is a common sleep-related breathing disorder that causes repeated interruptions in breathing during sleep. This can lead to decreased oxygen levels in the blood, causing strain on the cardiovascular system and other organs over time. It can lead to complications like hypertension, coronary heart disease, stroke, heart failure, atrial fibrillation and type II diabetes.The first study evaluated tirzepatidein OSA patients who used breathing devices called positive airway pressure  for 52 weeks. These patients had 27.4 fewer sleep apnea events per hour on treatment with tirzepatide, compared to 4.8 event reductions for the placebo group.This means a mean AHI reduction of 55.0%. Eli Lilly’s stock has risen 101.7% in the past year compared with an increase of 13.8% for the indus","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lillys-lly-tirzepatide-meets-125100908.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428804315","title":"Why Evolution Mining, Karoon Energy, ResMed, and Sayona Mining shares are dropping today","url":"https://stock-news.laohu8.com/highlight/detail?id=2428804315","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2428804315?lang=en_us&edition=fundamental","pubTime":"2024-04-18 12:06","pubTimestamp":1713413187,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index  is back on form and on course to deliver a solid gain on Thursday. In afternoon trade, the benchmark index is up a solid 0.55% to 7,648.5 points.Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:. The Sayona Mining share price is down almost 6% to 3.3 cents. This is despite there being no news out of the struggling lithium miner on Thursday. Though, it is worth noting that a number of lithium shares are trading lower today. Particularly those that have been targeted by short sellers. At the last count, approximately 7.2% for the lithium miner's shares were held by short sellers. This latest decline means that Sayona Mining's shares are now down by 15% since this time last week and 83% since this time last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/18/why-evolution-mining-karoon-energy-resmed-and-sayona-mining-shares-are-dropping-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428588539","title":"Why is the ResMed share price diving 5% today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2428588539","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2428588539?lang=en_us&edition=fundamental","pubTime":"2024-04-18 09:44","pubTimestamp":1713404686,"startTime":"0","endTime":"0","summary":"The ResMed Inc  share price is having a tough session on Thursday.In morning trade, the sleep treatment company's shares are down 5% to $27.45.Investors have been hitting the sell button this morning after concerns over those pesky weight loss wonder drugs returned.For some time it has been well understood that weight loss drugs like Ozempic could help sufferers of obstructive sleep apnoea . This has largely been both theoretical and anecdotal.However, this has now been proven through a clinical trial undertaken by pharmaceutical giant Eli Lilly And Co , which has spooked investors.Overnight, Eli Lilly and Co announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials.The release also notes that percentage change in AHI was a key secondary endpoint in both studies. AHI records the number of times a person's breathing shows a restricted or complete block of airflow per hour of sleep and is used to evaluate the severity of obstructive sleep apnea  and the effectiveness","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/18/why-is-the-resmed-share-price-diving-5-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428929304","title":"Advanced Human Imaging Releases Mid-Year Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2428929304","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2428929304?lang=en_us&edition=fundamental","pubTime":"2024-04-18 08:39","pubTimestamp":1713400746,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Human Imaging Ltd, a company with a strong corporate governance structure, ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-releases-mid-year-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-releases-mid-year-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2428830498","title":"Advanced Health Imaging Faces Steep Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2428830498","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2428830498?lang=en_us&edition=fundamental","pubTime":"2024-04-18 08:38","pubTimestamp":1713400694,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Health Intelligence Ltd reported a significant 85.6% drop in revenue and a 98...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-health-imaging-faces-steep-losses?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-health-imaging-faces-steep-losses?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2428316116","title":"Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2428316116","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428316116?lang=en_us&edition=fundamental","pubTime":"2024-04-17 19:04","pubTimestamp":1713351847,"startTime":"0","endTime":"0","summary":"Eli Lilly (NYSE:LLY) announced Wednesday that its weight loss therapy, tirzepatide, reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea (OSA), a sleep-relate","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1793099940/image_1793099940.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1793099940/image_1793099940.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4090375-eli-lilly-stock-gains-zepbound-succeeds-sleep-apnea","is_publish_highlight":false,"gpt_icon":0},{"id":"2428725390","title":"Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2428725390","media":"StreetInsider","top":-1,"share":"https://ttm.financial/m/news/2428725390?lang=en_us&edition=fundamental","pubTime":"2024-04-17 18:15","pubTimestamp":1713348900,"startTime":"0","endTime":"0","summary":"Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% , meeting all primary and key secondary endpoints in two phase 3 clinical trials. Tirzepatide meaningfully improved sleep apnea symptoms in those with moderate-to-severe OSA and obesity with and without PAP therapy, and based on these results Lilly plans to submit these data for global regulatory reviews. SURMOUNT-OSA Study 2 evaluated tirzepatide in adults with moderate-to-severe OSA and obesity who were on and planned to continue to use PAP therapy for 52 weeks. In this population for the efficacy estimand, at 52 weeks, tirzepatide led to a mean AHI reduction from baseline of 30.4 events per hour compared to a mean AHI reduction from baseline of 6.0 events per hour for placebo. In key secondary outcomes, tirzepatide led to a mean AHI reduction from baseline of 62.8% compared to 6.4% from baseline for placebo; tirzepatide also led to a mean body weight reduction of 20.1% from baseline, compared to 2.3% from baseli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=23076245","is_publish_highlight":false,"gpt_icon":0},{"id":"2427182766","title":"AHI Extends Changlin’s License Agreement Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2427182766","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2427182766?lang=en_us&edition=fundamental","pubTime":"2024-04-16 21:27","pubTimestamp":1713274064,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. Unsponsored Adr (AHI) has released an update. Advanced Health Intelligence Ltd. has extended the deadline until June 30...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ahi-extends-changlins-license-agreement-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ahi-extends-changlins-license-agreement-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2427173000","title":"Advanced Human Imaging Announces New Share Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2427173000","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2427173000?lang=en_us&edition=fundamental","pubTime":"2024-04-15 12:17","pubTimestamp":1713154635,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Human Imaging Ltd. has announced a new securities issuance of 29 million ordi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-announces-new-share-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-human-imaging-announces-new-share-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2427175810","title":"Advanced Health Intelligence Boosts Expansion Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2427175810","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2427175810?lang=en_us&edition=fundamental","pubTime":"2024-04-15 12:07","pubTimestamp":1713154067,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Health Intelligence Ltd. has initiated a comprehensive funding strategy, secu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-health-intelligence-boosts-expansion-funds?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-health-intelligence-boosts-expansion-funds?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2427093921","title":"AHI Expands Digital Health Footprint in MENA","url":"https://stock-news.laohu8.com/highlight/detail?id=2427093921","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2427093921?lang=en_us&edition=fundamental","pubTime":"2024-04-15 08:18","pubTimestamp":1713140308,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Health Intelligence Ltd announces the extension of its Master Services Agreem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ahi-expands-digital-health-footprint-in-mena?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ahi-expands-digital-health-footprint-in-mena?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2426248847","title":"AHI Extends Licensing Deal with Changlin in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2426248847","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426248847?lang=en_us&edition=fundamental","pubTime":"2024-04-12 07:47","pubTimestamp":1712879268,"startTime":"0","endTime":"0","summary":"Advanced Human Imaging Ltd. (AU:AHI) has released an update. Advanced Health Intelligence Ltd. has granted Shanghai-based Changlin Network Technolo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ahi-extends-licensing-deal-with-changlin-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ahi-extends-licensing-deal-with-changlin-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2423123425","title":"Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2423123425","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2423123425?lang=en_us&edition=fundamental","pubTime":"2024-03-28 20:05","pubTimestamp":1711627500,"startTime":"0","endTime":"0","summary":"Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating Expenses Decline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/03/28/2854464/0/en/Vivos-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Operational-Update.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421954062","title":"Sleep-Tech Company Nyxoah (NASDAQ: NYXH) Receives Bullish Price Target Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2421954062","media":"WallStreetZen","top":-1,"share":"https://ttm.financial/m/news/2421954062?lang=en_us&edition=fundamental","pubTime":"2024-03-21 15:30","pubTimestamp":1711006200,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus's Jonathan Block raised their price target on Nyxoah Sa (NASDAQ: NYXH) by 35% from $20 to $27 on 2024/03/20. The analyst maintained their Strong Buy rating on the stock.Block's updated","market":"us","thumbnail":"https://images.unsplash.com/photo-1517898717281-8e4385a41802?crop=entropy&cs=tinysrgb&fit=crop&fm=jpg&ixid=M3w0NDY2OTN8MHwxfGFsbHx8fHx8fHx8fDE3MDY4NjAyNTh8&ixlib=rb-4.0.3&q=80&w=260&utm_source=wallstreetzen&utm_medium=referral&utm_campaign=api-credit&h=180","type":0,"news_type":0,"thumbnails":["https://images.unsplash.com/photo-1517898717281-8e4385a41802?crop=entropy&cs=tinysrgb&fit=crop&fm=jpg&ixid=M3w0NDY2OTN8MHwxfGFsbHx8fHx8fHx8fDE3MDY4NjAyNTh8&ixlib=rb-4.0.3&q=80&w=260&utm_source=wallstreetzen&utm_medium=referral&utm_campaign=api-credit&h=180"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.wallstreetzen.com/news/sleep-tech-company-nyxoah-nasdaq-nyxh-receives-bullish-price-target-update","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ahi.tech","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.1935},{"period":"1year","weight":0.1711},{"period":"ytd","weight":-0.3151}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It develops and patents BodyScan, a proprietary measurement/dimensioning technology that enables end-user to check and assess body dimensions using a smartphone. The company also provides FaceScan for measuring vital signs, and risks associated with cardiovascular disease, heart attack, and stroke; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.","exchange":"NASDAQ","name":"ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS","nameEN":"ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS(AHI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS(AHI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS,AHI,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票老虎,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票老虎国际,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS行情,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票行情,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股价,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股市,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票价格,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票交易,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票购买,ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS(AHI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS(AHI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction